Microdose clinical trial - Impact of PET molecular imaging

Japanese Journal of Cancer and Chemotherapy

Volumn 37, Issue 10, 2010, Pages 1839-1848

  Yano, Tsuneo ^a   Watanabe, Yasuyoshi ^a  

^a RIKEN   (Japan)

Author keywords

Biological product; Exploratory IND study; Microdose clinical trial; Molecular imaging; PET

Indexed keywords

BIOLOGICAL MARKER;

DRUG DEVELOPMENT; INFECTION; MOLECULAR IMAGING; NEOPLASM; POSITRON EMISSION TOMOGRAPHY; REVIEW;

EID: 79960799814     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Radioisotopes 58(3):101-113, 2009.
2. Pharm Tech Jpn 25(14):7-16, 2009.
3. Jansen WTM, Verel A, Verhoef J, et al: In vitro activity of AR-709 against Streptococcus pneumonia. Antimicrobial Agents Chemother 52:1182-1183, 2008.
4. Lappin G, Warrington S, Sanghera D, et al: Plasma pharmacokinetics of AR-709 administered to male healthy volunteers as microdoses by the intravenous and oral route, Poster #F1-939, the 47th ICAAC in Chicago, 20 September 2007.
5. Lappin G, Warrington S, Honeybourne D, et al: Concentrations of AR-709 in plasma and key compartments of the lungs after microdosing, Poster #F1-938, the 47th ICAAC in Chicago, 20 September 2007.
6. Pharm Tech Jpn 24(9):19-28, 2008,
7. 18F] Ciprofloxacin, a new positron emission tomography tracer for noninvasive assessment of the tissue distribution and pharmacokinetics of ciprofloxacin in humans. Antimicrobial Agents Chemother 48:3850, 2004.
8. 18F-labeled fluconazole in healthy human subjects by positron emission tomography. Antimicrobial Agents Chemother 37:1270-1277, 1993. (Pubitemid 23166726)
9. 11C] Ro 64-0802 in mice. Nuclear Med Biol 36:47-55, 2009.
10. Juweid ME, Stroobants S, Hoekstra OS, et al: Use of positron emission tomography for response assessment of lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 25:571-578, 2007. (Pubitemid 350002965)
11. Cheson BD, Pfistner B, Juweid ME. et al: Revised response criteria for malignant lymphoma. J Clini Oncol 25:579-586, 2007. (Pubitemid 350002966)
12. Kawada K, Murakami K, Sato T, et al: Prospective study of positron emission tomography for evaluation of the activity of lapatinib, a dual inhibitor of the erbB1 and erbB2 tyrosine kinases, in patients with advanced tumors. Jpn J Clin Oncol 37(1):44-48, 2007. (Pubitemid 47090722)
13. 18F] FAHA-PET. The 2010 SNM Annual Meeting, June 8, 2010 (Salt Lake City).
14. Smith-Jones PM, Pandit-Taskar N, Cao W, et al: Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003. Nucl Med Biol 35:343-351, 2008. (Pubitemid 351381971)